Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another

Abstract Rasburicase was introduced to treat hyperuricemia secondary to tumor lysis syndrome. Because of severe hemolytic anemia, a blood smear was requested and showed hemighosts, revealing G6PD deficiency. Erythrocyte morphology is a key tool in laboratory hematology.

Bibliographic Details
Main Authors:	Pierre Cabantous, Sylvie Daliphard, Victor Bobée
Format:	Article
Language:	English
Published:	Wiley 2020-10-01
Series:	Clinical Case Reports
Subjects:	G6PD deficiency hematology hemolytic anemia methemoglobin venetoclax
Online Access:	https://doi.org/10.1002/ccr3.3011

id	doaj-218fc0fa395d48f1b70113b542325ca1
record_format	Article
spelling	doaj-218fc0fa395d48f1b70113b542325ca12020-11-25T03:44:28ZengWileyClinical Case Reports2050-09042020-10-018102069207010.1002/ccr3.3011Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide anotherPierre Cabantous0Sylvie Daliphard1Victor Bobée2Department of Biological Hematology Rouen University Hospital Rouen FranceDepartment of Biological Hematology Rouen University Hospital Rouen FranceDepartment of Biological Hematology Rouen University Hospital Rouen FranceAbstract Rasburicase was introduced to treat hyperuricemia secondary to tumor lysis syndrome. Because of severe hemolytic anemia, a blood smear was requested and showed hemighosts, revealing G6PD deficiency. Erythrocyte morphology is a key tool in laboratory hematology.https://doi.org/10.1002/ccr3.3011G6PD deficiencyhematologyhemolytic anemiamethemoglobinvenetoclax
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Pierre Cabantous Sylvie Daliphard Victor Bobée
spellingShingle	Pierre Cabantous Sylvie Daliphard Victor Bobée Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another Clinical Case Reports G6PD deficiency hematology hemolytic anemia methemoglobin venetoclax
author_facet	Pierre Cabantous Sylvie Daliphard Victor Bobée
author_sort	Pierre Cabantous
title	Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another
title_short	Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another
title_full	Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another
title_fullStr	Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another
title_full_unstemmed	Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another
title_sort	erythrocyte hemighosts in a patient with tumor lysis syndrome: one train may hide another
publisher	Wiley
series	Clinical Case Reports
issn	2050-0904
publishDate	2020-10-01
description	Abstract Rasburicase was introduced to treat hyperuricemia secondary to tumor lysis syndrome. Because of severe hemolytic anemia, a blood smear was requested and showed hemighosts, revealing G6PD deficiency. Erythrocyte morphology is a key tool in laboratory hematology.
topic	G6PD deficiency hematology hemolytic anemia methemoglobin venetoclax
url	https://doi.org/10.1002/ccr3.3011
work_keys_str_mv	AT pierrecabantous erythrocytehemighostsinapatientwithtumorlysissyndromeonetrainmayhideanother AT sylviedaliphard erythrocytehemighostsinapatientwithtumorlysissyndromeonetrainmayhideanother AT victorbobee erythrocytehemighostsinapatientwithtumorlysissyndromeonetrainmayhideanother
_version_	1724514799745761280

Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another

Similar Items